Published in Am J Physiol on July 01, 1988
Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation. J Clin Invest (2000) 1.78
K(ATP)-mediated vasodilation is impaired in obese Zucker rats. Microcirculation (2008) 0.95
Attenuated PGI2 synthesis in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol (2008) 0.88
Are Frozen Foods a Public Health Problem? Am J Public Health Nations Health (1947) 3.44
Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med (2005) 3.13
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
No evidence for lipid peroxidation in severe preeclampsia. Am J Obstet Gynecol (2001) 2.28
Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo. FASEB J (1998) 1.89
Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol (1993) 1.76
Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Arch Gen Psychiatry (1993) 1.60
Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med (1994) 1.54
Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J (1991) 1.54
Measurement of 6-oxo-PGF1 alpha in human plasma using gas chromatography-mass spectrometry. Prostaglandins (1979) 1.48
Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radic Biol Med (2005) 1.42
Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man. J Pharmacol Exp Ther (1995) 1.38
Paracetemol poisoning--a brief report. Ir Med J (1977) 1.32
The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha. J Pharmacol Exp Ther (1997) 1.31
Circadian rhythm of baroreflex reactivity and adrenergic vascular response. Cardiovasc Res (1980) 1.15
Sanitation and Quality Control in the Fishery Industries. Am J Public Health Nations Health (1937) 1.15
Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. Am J Respir Crit Care Med (1998) 1.12
Increased excretion of leukotriene E4 during aspirin-induced asthma. J Lab Clin Med (1992) 1.11
Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon. Br Med J (Clin Res Ed) (1986) 1.10
Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin. Am Rev Respir Dis (1990) 1.08
Point mutation in the seventh hydrophobic domain of the human thromboxane A2 receptor allows discrimination between agonist and antagonist binding sites. Mol Pharmacol (1993) 1.07
Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator. Proc Natl Acad Sci U S A (1989) 1.04
Circulating adrenaline and blood pressure: the metabolic effects and kinetics of infused adrenaline in man. Eur J Clin Invest (1980) 1.04
Circadian variation in adrenergic responses in asthmatic subjects. Clin Sci (Lond) (1982) 1.00
Measurement of renal and non-renal eicosanoid synthesis. Am J Med (1986) 0.99
Allergen-stimulated release of mediators into sheep bronchoalveolar lavage fluid. Effect of cyclooxygenase inhibition. Am Rev Respir Dis (1989) 0.96
Long-lived enzymatic metabolites of thromboxane B2 in the human circulation. Anal Biochem (1986) 0.95
Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease. J Intern Med (2008) 0.94
Reduced brain metabolism in hyperactive girls. J Am Acad Child Adolesc Psychiatry (1994) 0.93
Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation. J Pharmacol Exp Ther (1991) 0.93
Endogenous prostacyclin synthesis is decreased during activation of the renin-angiotensin system in man. J Clin Endocrinol Metab (1984) 0.90
Cellular activation by thromboxane A2 and other eicosanoids. Eur Heart J (1993) 0.89
Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs. Am J Physiol Lung Cell Mol Physiol (2000) 0.89
Biopharmaceutical characterisation of a low-dose (75 mg) controlled-release aspirin formulation. Br J Clin Pharmacol (1993) 0.89
Leukotriene B4 synthesis and neutrophil chemotaxis in chronic granulocytic leukaemia. J Clin Pathol (1988) 0.88
Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects. J Pharmacol Exp Ther (1982) 0.87
The immunogenicity of Haemophilus influenzae type b conjugate vaccines in children born to human immunodeficiency virus-infected women. Women and Infants Transmission Study Group. Pediatr Infect Dis J (1998) 0.86
Intravenous prostacyclin in thrombotic thrombocytopenic purpura. Ann Intern Med (1981) 0.84
The translational therapeutics of prostaglandin inhibition in atherothrombosis. J Thromb Haemost (2009) 0.83
Thromboxane biosynthesis in allergen-induced bronchospasm. Evidence for platelet activation. Am Rev Respir Dis (1989) 0.81
Effects of dietary fat content, saturated fatty acids, and fish oil on eicosanoid production and hemostatic parameters in normal men. J Lab Clin Med (1994) 0.80
Eicosanoid biosynthesis in human cardiovascular disease. Hum Pathol (1987) 0.80
Effects of intravenous dextroamphetamine on brain metabolism in adults with attention-deficit hyperactivity disorder (ADHD). Preliminary findings. Psychopharmacol Bull (1994) 0.79
No evidence for antagonism of clonidine by naloxone in man [proceedings]. Br J Clin Pharmacol (1980) 0.78
Pre and postsynaptic alpha-receptor agonists and the rate of release of noradrenaline in man [proceedings]. Br J Clin Pharmacol (1979) 0.78
Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment. J Thromb Haemost (2003) 0.78
Histocompatibility antigens and haemochromatosis in Ireland. Ir J Med Sci (1980) 0.78
Cyclooxygenase-dependent formation of the isoprostane 8-epi prostaglandin F2 alpha. Ann N Y Acad Sci (1994) 0.78
Aspirin reduces the prothrombotic activity of C-reactive protein. J Thromb Haemost (2009) 0.78
Comparative impact on prostanoid biosynthesis of celecoxib and the novel nonsteroidal anti-inflammatory drug CG100649. Clin Pharmacol Ther (2012) 0.77
Molecular cloning of the human platelet 12-lipoxygenase. Trans Assoc Am Physicians (1990) 0.77
Cellular activation of thromboxane receptors. Ann N Y Acad Sci (1994) 0.77
A prostacyclin analog impairs the response to tissue-type plasminogen activator during coronary thrombolysis: evidence for a pharmacokinetic interaction. J Pharmacol Exp Ther (1991) 0.77
Cellular activation by thromboxane A2 and 8-EPI-PGF2 alpha. Adv Exp Med Biol (1997) 0.76
Cyclooxygenase dependent formation of 8-iso-prostaglandin F2 alpha by human platelets. Adv Prostaglandin Thromboxane Leukot Res (1995) 0.76
The effect of prostacyclin on pituitary hormone release. Br J Clin Pharmacol (1980) 0.76
Vovulus of the small bowel in a diabetic patient. Br Med J (1976) 0.75
Hypertensive crisis in prazosin-treated pheochromocytoma. South Med J (1984) 0.75
HLA identity in juvenile onset diabetes. Ir J Med Sci (1978) 0.75
Digitoxin-quinidine interaction: potentiation during administration of cimetidine. South Med J (1981) 0.75
Cryoglobulinaemia in Henoch-Schönlein purpura. Br Med J (1977) 0.75
Consequences dietary ethanol on permeability and respiration of mitochondria and liver ADH in young and aged rats. Curr Alcohol (1979) 0.75
Antiplatelet and anticoagulant therapy during coronary thrombolysis. Trends Cardiovasc Med (2011) 0.75
One hundred days in a general medical/specialist unit--sources of referral and length of hospital stay. Ir Med J (1979) 0.75
Beta-adrenoreceptor down-regulation by dynamic exercise and upright posture in man. Trans Assoc Am Physicians (1981) 0.75
Prostaglandins. Ir Med J (1982) 0.75
Vascular effects of infused adenosine are not mediated by prostacyclin release in humans. Am J Physiol (1987) 0.75
The kinetics and concentration-effect relationships of circulating adrenaline in man [proceedings]. Br J Clin Pharmacol (1980) 0.75
Health Problems in Packing Crustacean Products. Am J Public Health Nations Health (1939) 0.75
Erythrocytes catechol-O-methyltransferase activity and indices of sympathetic activity in man. Clin Sci (Lond) (1980) 0.75